Accell’s team recently attended an industry-leading event, Medidata NEXT New York 2023 conference, held on November 7-8 in the heart of Midtown Manhattan.
CPHI Frankfurt was a definitive go-to event that united over 100,000 pharmaceutical professionals and 1,000 exhibitors presenting their pharmaceutical products, solutions, and services across the full supply chain.
Romania is turning into an attractive destination for your next clinical trial thanks to the legislation update guaranteeing a 60-day approval by the Romanian regulatory authority.
On July 4, 2022, the CRO has expanded its presence in the European Union by opening a new office in Bucharest, Romania. Daniela Pirvu, MD, has been named Head of the European Clinical Operations Division.
It was a pleasure to attend Accell’s first post-COVID in-person event – ASCO Annual Meeting 2022, a leading global event that unites oncology research-related organizations and experts from all over the world.
Accell Clinical LLC continues its operations across Eastern Europe and CIS countries and offers its clinical research services in such countries as: Bulgaria, Croatia, Estonia, Georgia, Hungary, Kazakhstan, Latvia, Lithuania, Montenegro, Poland, Romania, and Serbia.
During these hard times, when the world got overwhelmed with the pandemic and economic consequences, we wanted to assure you that Accell keeps working to its fullest extent.
On February 26-28, 2020 Natalia Nayanova, Accell’s Managing Member, headed to New York City, NY to attend the annual conference “Immuno-Oncology 360°” held in Crowne Plaza Times Square. Organized by The Conference Forum, Immuno-Oncology 360° convenes...
In November 2019 Syntax for Science and Accell Clinical Research announced their strategic CRO partnership to enhance clinical trial performance, overall Sponsor’s experience, and their geographic coverage.
BIO-Europe® is held annually in different cities and is an international forum to promote business development between pharmaceutical, financial, and biotechnology companies. In November 2019 Natalia Nayanova, Accell’s founder and Managing Member, attended BIO-Europe...
The ESMO Congress is the appointment in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology and translate science into better cancer...
In July, 2019 Natalia Nayanova, Accell’s Founder and Managing Member, went all the way to Taiwan to attend the BIO Asia conference held on July 22-26, 2019.
On July 3-5, 2019 Accell’s annual corporate training 2019 brought together the whole team not only from Accell’s Russian office but from the USA as well.
On June 6-7, 2019, Accell’s team participated in a local conference “Clinical Trials in the Eurasian Economic Union (EAEU)” held in Saint Petersburg, Russia.
Accell continued its collaboration with the world’s leading oncology event – ASCO Annual Meeting. Here are some of ASCO 2019 highlights that we spotted.
Accell Oncology is ready to introduce an innovative approach to organize advisory boards and provide consultancy services with oncology key opinion leaders (KOLs) at the top-level of expertise via unique partner online oncology forum – “OncoForum”.
The year of 2019 began for Accell with the visit of Natalia Nayanova, Accell’s Founder and Director of Clinical Operations, to Orlando, Florida on January 22-24; Natalia attended 8th Annual CROWN Congress. This was an elite gathering of clinical decision-makers aiming...
It is the end of 2018, so it is high time to summarize our company’s success over the past year. Natalia Nayanova, Accell’s Founder and Clinical Operations Director, shares her perspective on the company’s overall progress: “I don’t wish to brag, but Accell once again...
On November 13-14, 2018 Natalia Nayanova, Accell’s Founder and Director of Clinical Operations, attended an Adam Smith Conference ‘Clinical Trials Russia 2018’ held in Moscow, Russia. This is the only international event that is dedicated to discussing the regulatory,...
This October Accell has exhibited for the first time at ESMO Annual Congress 2018. The event was held in Munich, Germany from October 18 until October 22, 2018. The European Society for Medical Oncology (ESMO) is the leading European professional organization for...
In September 2018 Accell Clinical Research became an official member of Clinical & Contract Research Association (CCRA) and agreed to abide by the Code of Practice. CCRA is an influential trade organization for UK companies involved in biopharmaceutical research....
On September 14, 2018, GHP magazine announced Accell Clinical Research as one of the winners of the Healthcare & Pharmaceutical Awards 2018, ‘The Best Clinical Trial Management Firm – Eastern Europe’.
On August 7, 2018, Accell’s team had the honor to meet a delegation from The Wuhan National Bio-industry Base and welcome it at our Clinical Operations Headquarters in Saint Petersburg, Russia.
As most of you know the FIFA World Cup 2018 has just triumphantly ended in Russia. This event brought hundreds of thousands of football fans from all over the world to witness a spectacular month-long tournament all dedicated to soccer. It is high time now to...
Currently, the whole world awaits implementation of Clinical Trial Regulation EU No. 536/2014by the European Medicines Agency (EMA). It comes in collaboration with the Member States and the European Commission. According to the recent update on the EMA website, the...
This year Accell Clinical Research celebrated its 3d anniversary of exhibiting at the leading oncology industry event by presenting its new branch – Accell Oncology.
On March 12-14, 2018 Accell’s business development team came to Amsterdam to unite at the main springtime partnering conference in Europe. Discover our insights.
This March Accell’s Business Development team is excited to welcome on board Mr. Lester Powell, Associate Business Development Director based in the United Kingdom.
Accell’s business development team exhibited in Boston at Arena International’s Conference tailored specifically for experts in oncology clinical operations.
Accell emphasizes constant education and development for every team member. On June 21-23 Accell’s team had an offsite training and a 10-year anniversary celebration.
For the second year in a row, Accell Clinical Research has had a privileged opportunity of exhibiting at the Annual Meeting of the American Society of Clinical Oncology (ASCO). Taking place in Chicago from June 2 to 6, 2017, ASCO drew more than 30,000 oncology...
This April Accell’s Director of Clinical Operations, Natalia Nayanova, attends a scientific and practical conference “Expertise and registration of drugs in the Eurasian Economic Union (EAEU)” organized by the “Scientific Centre for Expertise of Medical Applications”...
The flagship Outsourcing in Clinical Trials event on the West Coast returned to Burlingame, California on February 22-23 2017. The event brought together more than 700 clinical professionals not only from San Francisco Bay Area, but from all over the globe. Accell...
The 8th Annual SCOPE Summit took place January 24-26, 2017 in Miami, FL, offering three stimulating days of in-depth discussions in 13 different conferences, 6 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning...
Accell business development team will attend Clinical Operations in Oncology Trials Europe 2016 conference held on November 29-30 in Amsterdam, Netherlands. This year’s European conference returns for its 3rd Annual edition and aims at exploring new ways to improve...
Accell Clinical Research has been delighted to intensely participate in major global life science events in 2016; this October meet our Business Development team at ESMO 2016 oncology conference held on October 7-11 in Copenhagen, Denmark. The annual ESMO congress is...
September 2016 is an eventful month for Accell Clinical Research business development team: Julia Kondakov, Director of Business Development and Accell’s Co-founder, will attend the conference ‘Women Building Bio: the XX Factor’ this Thursday, September 29, 2016....
This is Accell’s inaugural year of exhibiting at Nordic Life Science Days, the largest Nordic partnering conference for the global Life Science. Nordic Life Science Days is held in Stockholm on September 14-15, 2016 and attracts leading decision makers from the Life...
It is a second year in a row that Accell Clinical Research is participating in Clinical Operations in Oncology Trials (CTO) East Coast in the Boston biotech hub. CTO is the only operationally-focused oncology conference in the USA with a dynamic program specifically...
Charlottesville Biotech and Beer Event at UVA is coming up on May 10th! Julia Kondakov will attend this VirginiaBIO networking event – please come find us there. Tuesday, May 10th at 5:50, I.Lab at UVA. To pre-schedule meetings, contact Julia Kondakov at...
Accell Clinical Research will exhibit at the Outsourcing in Clinical Trials East Coast 2016, May 25-26 2016, King of Prussia, PA. It is an established conference bringing together more than 350 pharmaceutical industry professionals. Julia Kondakov will be there to...
OCT Israel 2016 in Tel Aviv is in less than a month — March 14-15, 2016. We are looking forward to exhibiting for the second consecutive year. Come by our booth to speak with Natalia Nayanova, our Director of Clinical Operations, and Julia Kondakov, Director of...
Accell Clinical Research is exhibiting at the 5th Annual Outsourcing in Clinical Trials Southeast 2016, 5th-16th March 2016, Cary, North Carolina, USA. Make sure to stop by booth 9A and meet the Accell Clinical Research Team. To pre-schedule meetings, contact Svetlana...
Accell Clinical Research Director of Clinical Operations, Dr. Natalia Nayanova’s presentation at the 2015 Clinical Operations in Oncology Trials conference in Amsterdam was a great success. We look forward to seeing you next year. Oncology Treatment Network Structure...
The 3rd annual Clinical Trails Conference Russia 2015 is next week, 24th–26th November at the Metropol hotel, Moscow, Russia. Accell Clinical Research’s director of Clinical Operations, Natalia Nayanova, will participate in a panel discussion on Wednesday, Nov. 25th...
Natalia Nayanova, Director of Clinical Operations, Accell Clinical Research, will be at the Clinical Operations in Oncology Trials (Europe) from December 1st–2nd 2015 in Amsterdam, Netherlands. She will speak on the topic; “Oncology Treatment Network Structure in...
Natalia Nayanova, Director of Clinical Operations, Accell Clinical Research, will speak at the “Clinical Trials Innovation Programme” conference (October 22-23, Frankfurt, Germany). The Clinical Trials Innovation Programme (CTIP) 2015 is an exclusive, invitation-only...
“Accell Clinical Research is proud to announce the receipt of the 2015 CRO Leadership Award on Reliability, presented by Life Science Leader magazine. The award is a result of feedback survey by pharmaceutical and biotech companies in various categories of CRO...
Accell Clinical Research will exhibit at the 4th Annual Clinical Operations in Oncology Trials on July 15–16 in Boston, Massachusetts. Drop by Booth #20 to discuss your clinical trial pipeline with our specialists and to learn about the benefits of oncology research...
Accell Clinical Research will participate in 2015 BIO International Convention (June 15-18, 2015, Philadelphia, PA). Visit us at the exhibition to discuss opportunities of conducting clinical trials in Russia & Eastern Europe with our leading specialists! For...
Accell Clinical Research will exhibit at the DIA 51st Annual Meeting on June 14-18 in Washington, DC. Drop by Booth #2439 to discuss your clinical trial pipeline with our specialists and to learn about benefits of clinical research in Eastern Europe. We will be happy...
A Phase III clinical study of active ulcerative colitis treatment has moved into its final stage at Accell Clinical Research. The study commenced in August 2012 and included 30 sites managed by our team in Russia, Ukraine, Lithuania and Latvia. Our sites showed...
Accell has commenced two Phase III clinical trials testing the efficacy of a new drug for prevention of major cardiovascular events in risk group patients. Thirty Russian sites managed by Accell will participate in both studies. The Sponsor of the trial is a major...
One of Accell’s clients, a developer of targeted therapeutics for various tumor types, starts 2 new Phase II clinical trials in Russia. Accell has been performing other clinical studies for this innovative cancer therapy since 2013. The client develops a method of...
Natalia Nayanova, Director, Clinical Operations at Accell Clinical Research, spoke at annual international scientific conference “Multidisciplinary clinic in ХХI. Extreme medicine” (St. Petersburg, April, 9-11). The topic of presentation was “High-quality clinical...
Accell Clinical Research invites biotech and pharmaceutical companies in Israel to Outsourcing in Clinical Trials Israel 2015. OCT Israel will provide a platform for local biotech and pharmaceutical companies to expand their industry network, explore proven strategies...
Accell Clinical Research will participate in the international cross-disciplinary conference “Non-small-cell Lung Cancer” (Moscow, February 26-27) organized by RUSSCO (Russian Association of Clinical Oncology). We shall conduct a medical workshop as a part of one of...
Accell Clinical Research will participate in the Clinical Trials Innovation Programme (CTIP) — an exclusive, invitation-only event held annually, helping senior executives from pharma & biotech industries to forge strong and lasting business relationships and to...
Accell Clinical Research will participate in the “Innovative Drug R&D Russia 2014” conference (November 18-19, 2014, Moscow). Accell has participated in this event since 2012, this year we are going there to meet our existing and future business partners again....
Accell Clinical Research specialists will attend the 20th Annual Russian Pharmaceutical Forum held by Adam Smith Conferences on June 17-19, 2014 in Saint Petersburg, Russia. This event brings together the top players of the Russian pharmaceutical industry. We will be...
Accell Clinical Research will exhibit at the DIA 50th Annual Meeting on June 16-18 in San Diego, CA. Drop by Booth #2411 to discuss your clinical trial pipeline with our specialists and to learn about benefits of clinical research in Eastern Europe. We will be happy...
Accell will participate in 2nd Launching New Pharmaceuticals in Russia and CIS conference dedicated to developing the market of pharmaceuticals in CIS. Natalia Nayanova, Director of Clinical Operations will give a presentation on “Clinical trial as a part of...
Accell will participate at Arena International’s 6th Annual Outsourcing in Clinical Trials West Coast Conference dedicated to an exploration of strategies to form long-term effective partnerships with solution providers, whilst maintain budgets and trial deadlines. We...
A clinical site managed by ACCELL in Russia in a clinical study with patients suffering from Haemophilia A has been inspected by EMEA in December 2013. No critical findings have been identified during the course of the inspection and the study was found to be...
We have achieved our First Patient In (FPI) milestone in the Phase II clinical study in patients with Non-Small Cell lunch Cancer (NSCLC). The clinical study is being conducted at 7 sites in Russia after the recent approval by the Ministry of Health of two additional...
Accell is commencing a clinical study in healthy volunteers for a Hepatitis B vaccine. The clinical study has received the approval of Ministry of Health as a part of the medicinal product registration application. The clinical study will recruit 100 subjects in Saint...
We are in the process of obtaining the Registration Certificate (Marketing Authorization) in Russian Federation for a medical device manufactured by a multinational pharmaceutical and diagnostics company. The device is a robust point-of-care analyzer complete with...
immunogenicity of a recombinant vaccine against Hepatitis B in adult healthy subjects. Accell will be responsible for regulatory, clinical, data management, statistics and medical writing and will randomize 100 subjects at Russian sites.
Accell Clinical Research will partake at Adam Smith Conferences 4th annual Forum comprising two events such as Clinical Trials Russia Forum & Innovative Drug Research and Development in Russia. We look forward to meeting our friends and clients in Moscow. All...
“We are thrilled to be expanding our relationship with Accell”, said Timur Galimov, Technical Director of Flex Databases. “It has been a pleasure to work with Accell who are a dynamic company open to innovation. We are glad to see them leverage the...
Accell Clinical Research will participate at Arena International’s 5th annual Outsourcing in Clinical Trials New England conference dedicated to a varied yet balanced range of topics to ensure an in-depth overview of Outsourcing in Clinical Trials. We look forward to...
We have obtained regulatory approval for a Phase II study in patients with NSCLC. The clinical study will be conducted at 6 sites in Russia and will enroll 20 patients.
We are delighted to inform our valued clients and partners that we have recently moved our Russian clinical headquarters into a larger office space located just a few steps from our former location. The new office address is Finlyandsky pr., 4-A, Suite 623, Saint...
This year will be the seventh consecutive year of attendance at this highly interesting industry event. We look forward to meeting our friends and clients in Chicago. All questions may be addressed to Mrs. Julia Kondakov, Director, Business Development...
This Phase III study will be performed at 14 sites across Russian Federation and will recruit 65 patients suffering from primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis over the period of 12 months.
Accell Clinical Research will participate in the Adam Smith Conferences’ 3rd annual Forum dedicated to Innovative Drug Research and Development in Russia taking place on 21 – 23 November 2012 in Moscow. Natalia Nayanova, Director of Clinical Operations,...
In an ongoing clinical study in Russian Federation in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D), recruitment expectations were exceeded. Actual enrolment of patients at the time of LPI was 37% above the number of...
Accell’s team in Saint Petersburg, Russia has increased by four new members since January 2012. We welcome our new Clinical Research Associates to the clinical department. Currently openings remain for new Clinical Research Associates (CRAs) in Russia, Ukraine,...
We started a new international phase III study with patients suffering from acute ulcerative colitis. The study will enroll more than 300 patients in 30 sites in Lithuania, Latvia, Russia and Ukraine. Enrollment in the clinical study will continue until December...
We have started a clinical study in Russia in 6 sites in patients with a recent coronary acute syndrome (ACS) and type 2 diabetes mellitus (T2D). The study will enroll 60 patients.
Accell has started a clinical study with 8 sites in Russia in patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Recently, the study has been extended to 16 sites.
Accell Clinical Research is pleased to welcome Dr. Zagit Gaymalov as a part of our team. Dr. Gaymalov joins us as a Business Development professional with a strong background in pharmaceutical and research industry. He will lead Business Development efforts in North...
Now more than before biotechnology and pharmaceutical companies are searching for ways to optimize their clinical development programs to ensure that clinical studies result in quality data accepted by regulatory agencies and are cost effective. Many companies...
Maximax Pharmaceutical Research Inc. launches a global CRO Development Group and expands its strategic alliances with several regional CRO’s to increase the scale, scope and geographic locations of its services to Bio-pharmaceutical companies and research...
Nov. 4-5, 2010. Accell Clinical Research participated in the conference “Clinical Trials for Pharmaceutical Products in the Ukraine 2010” in Kiev, Ukraine. Accell is actively expanding its activities in the Ukraine with several clinical studies underway....
The clinical study will be conducted at 17 clinical sites across Russian Federation. 210 subjects suffering from Deep Venous Thrombosis will be enrolled in the clinical study. The study Sponsor is a large European pharmaceutical company.
Please visit our booth for a discussion of how we can meet your clinical trial needs in Russia, Ukraine and Eastern Europe. Contact Julia Kondakov for further information at bd@accellclinical.com.
April 2008 – Ministry of Health approval was granted to Accell Clinical Research to conduct a study in 5 centers in Russia in patients with solid tumors.
You are cordially invited to visit us in San Diego at Booth #5214 at BIO2008 and to learn more about conducting clinical studies in Russia and Eastern Europe. See ACCELL at BIO2008
We invite you to visit our Booth #250 at the DIA EuroMeeting in Barcelona on March 3-5, 2008 and discuss your clinical study requirements with members of our business development and clinical operations teams. For futher inquiries please contact Julia Kondakov,...
January 2008 – ACCELL received final approval from the Russian Ministry of Health to conduct a clinical study in patients with ulcerative colitis. Russian sites are a part of multinational clinical study
We are pleased to announce the expansion of our business development activities into the Netherlands. Mila Loginova has become a representative of Accell Clinical Research, LLC in the Netherlands as a Client Relations Manager. Mrs. Loginova is directly responsible for...
Company representatives will participate in the conference Partherships in Clinical Trials 2007. To arrange a meeting during the conference or to request additional information please contact Mila Loginova (Client Relations Manager, Netherlands) or Julia Kondakov...
ACCELL is exhibiting at BIO International Convention in Boston, MA on May 6-9, 2007. Booth #802. We would be happy to arrange a meeting, pelase come by to see us! Your contact person for all business related inquiries is Julia Kondakov, Director, Business Development....
Dr. Zykova is a Medical Doctor graduated from Pavlov State Medical University, Saint Petersburg, and has practiced as a general surgeon for 3 years. Subsequently, she focused her career on clinical research starting from 1998. Her previous experince includes various...
MOSCOW, April 16-20, 2007. ACCELL will participate in the 14th Russian National Congress “Human and Medicine”. We are dedicated to following the cutting-edge trends in the Russian medical community. We would be happy to meet with you during the Congress....
Welcome and enjoy! We have made every effort to make your browsing experience easy and enjoyable, as we do with all our services. Please don’t hesitate to call us or send an email for additional information.
Recent Comments